6.
Kleine-Borgmann J, Schmidt K, Hellmann A, Bingel U
. Effects of open-label placebo on pain, functional disability, and spine mobility in patients with chronic back pain: a randomized controlled trial. Pain. 2019; 160(12):2891-2897.
DOI: 10.1097/j.pain.0000000000001683.
View
7.
Volkow N, McLellan A
. Opioid Abuse in Chronic Pain--Misconceptions and Mitigation Strategies. N Engl J Med. 2016; 374(13):1253-63.
DOI: 10.1056/NEJMra1507771.
View
8.
Morales-Quezada L, Mesia-Toledo I, Estudillo-Guerra A, OConnor K, Schneider J, Sohn D
. Conditioning open-label placebo: a pilot pharmacobehavioral approach for opioid dose reduction and pain control. Pain Rep. 2020; 5(4):e828.
PMC: 7373570.
DOI: 10.1097/PR9.0000000000000828.
View
9.
Flowers K, Patton M, Hruschak V, Fields K, Schwartz E, Zeballos J
. Conditioned open-label placebo for opioid reduction after spine surgery: a randomized controlled trial. Pain. 2021; 162(6):1828-1839.
PMC: 8378225.
DOI: 10.1097/j.pain.0000000000002185.
View
10.
Carvalho C, Caetano J, Cunha L, Rebouta P, Kaptchuk T, Kirsch I
. Open-label placebo treatment in chronic low back pain: a randomized controlled trial. Pain. 2016; 157(12):2766-2772.
PMC: 5113234.
DOI: 10.1097/j.pain.0000000000000700.
View
11.
Wunsch H, Wijeysundera D, Passarella M, Neuman M
. Opioids Prescribed After Low-Risk Surgical Procedures in the United States, 2004-2012. JAMA. 2016; 315(15):1654-7.
PMC: 4837043.
DOI: 10.1001/jama.2016.0130.
View
12.
Sabatino M, Kunkel S, Ramkumar D, Keeney B, Jevsevar D
. Excess Opioid Medication and Variation in Prescribing Patterns Following Common Orthopaedic Procedures. J Bone Joint Surg Am. 2018; 100(3):180-188.
PMC: 6818977.
DOI: 10.2106/JBJS.17.00672.
View
13.
Brummett C, Waljee J, Goesling J, Moser S, Lin P, Englesbe M
. New Persistent Opioid Use After Minor and Major Surgical Procedures in US Adults. JAMA Surg. 2017; 152(6):e170504.
PMC: 7050825.
DOI: 10.1001/jamasurg.2017.0504.
View
14.
Vadivelu N, Kai A, Kodumudi V, Sramcik J, Kaye A
. The Opioid Crisis: a Comprehensive Overview. Curr Pain Headache Rep. 2018; 22(3):16.
DOI: 10.1007/s11916-018-0670-z.
View
15.
von Wernsdorff M, Loef M, Tuschen-Caffier B, Schmidt S
. Effects of open-label placebos in clinical trials: a systematic review and meta-analysis. Sci Rep. 2021; 11(1):3855.
PMC: 7887232.
DOI: 10.1038/s41598-021-83148-6.
View
16.
Bernstein M, Magill M, Weiss A, Kaptchuk T, Blease C, Kirsch I
. Are Conditioned Open Placebos Feasible as an Adjunctive Treatment to Opioids? Results from a Single-Group Dose-Extender Pilot Study with Acute Pain Patients. Psychother Psychosom. 2019; 88(6):380-382.
PMC: 6868304.
DOI: 10.1159/000503038.
View
17.
Jonas W, Crawford C, Colloca L, Kaptchuk T, Moseley B, Miller F
. To what extent are surgery and invasive procedures effective beyond a placebo response? A systematic review with meta-analysis of randomised, sham controlled trials. BMJ Open. 2015; 5(12):e009655.
PMC: 4679929.
DOI: 10.1136/bmjopen-2015-009655.
View
18.
Zaslansky R, Meissner W, Chapman C
. Pain after orthopaedic surgery: differences in patient reported outcomes in the United States vs internationally. An observational study from the PAIN OUT dataset. Br J Anaesth. 2018; 120(4):790-797.
PMC: 6200101.
DOI: 10.1016/j.bja.2017.11.109.
View
19.
Han B, Compton W, Blanco C, Crane E, Lee J, Jones C
. Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults: 2015 National Survey on Drug Use and Health. Ann Intern Med. 2017; 167(5):293-301.
DOI: 10.7326/M17-0865.
View
20.
Bernstein M, Locher C, Stewart-Ferrer S, Buergler S, DesRoches C, Dossett M
. Primary care providers' use of and attitudes towards placebos: An exploratory focus group study with US physicians. Br J Health Psychol. 2020; 25(3):596-614.
PMC: 7423714.
DOI: 10.1111/bjhp.12429.
View